Skip to Content
  • Ycombinator Gets Into Biotech

    Here’s an article from Nature News on the startup incubator company Ycombinator moving into biotech funding. Those of you familiar with them will wonder a… Read More
  • Shuffling the Departments

    So word comes this morning of some big transactions between Novartis, GlaxoSmithKline, and Eli Lilly: Novartis said it had agreed to buy GlaxoSmithKline’s… Read More
  • Pfizer Walks Again By Night

    So the Sunday Times came out with a story saying that Pfizer has attempted a bid for AstraZeneca. This is something of a surprise, at least for me. Pfizer has m… Read More
  • Novartis Gets Out of RNAi

    Yesterday brought the sudden news that Novartis is pulling their RNA interference research work. The company is citing difficulties in development, and also the… Read More
  • AstraZeneca’s Cambridge Move

    Here’s more on AstraZeneca’s move to Cambridge (UK). They’ve set up an agreement with the Medical Research Council to have MRC people working… Read More
  • Biotech Boom, Biotech Bust?

    Here’s a good one by Matthew Herper on “Three Misplaced Assumptions That Could End the Biotech Boom”. Given the way the biotech stock index ha… Read More
  • Outsourcing Everything

    Here’s an article in Drug Discovery Today on “virtual pharmaceutical companies”, and people who’ve been around the industry for some yea… Read More
Page 30 of 104« First...1020...2829303132...405060...Last »